SG11202005320VA - Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid - Google Patents
Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acidInfo
- Publication number
- SG11202005320VA SG11202005320VA SG11202005320VA SG11202005320VA SG11202005320VA SG 11202005320V A SG11202005320V A SG 11202005320VA SG 11202005320V A SG11202005320V A SG 11202005320VA SG 11202005320V A SG11202005320V A SG 11202005320VA SG 11202005320V A SG11202005320V A SG 11202005320VA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- aqueous solution
- injectable aqueous
- human glucagon
- copolyamino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
- C08L77/04—Polyamides derived from alpha-amino carboxylic acids
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762606137P | 2017-12-07 | 2017-12-07 | |
| FR1761809A FR3074683B1 (en) | 2017-12-07 | 2017-12-07 | COMPOSITIONS IN THE FORM OF AN AQUEOUS INJECTION SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINOACID |
| FR1855939 | 2018-06-29 | ||
| PCT/EP2018/084065 WO2019110837A1 (en) | 2017-12-07 | 2018-12-07 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005320VA true SG11202005320VA (en) | 2020-07-29 |
Family
ID=64899248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005320VA SG11202005320VA (en) | 2017-12-07 | 2018-12-07 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11191812B2 (en) |
| EP (1) | EP3720471B1 (en) |
| JP (1) | JP2021505597A (en) |
| KR (1) | KR20200107951A (en) |
| CN (1) | CN111670042A (en) |
| AU (1) | AU2018380993A1 (en) |
| BR (1) | BR112020011484A2 (en) |
| CA (1) | CA3084700A1 (en) |
| MA (1) | MA51017A (en) |
| SG (1) | SG11202005320VA (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190216931A1 (en) | 2017-12-07 | 2019-07-18 | Adocia | Injectable ph 7 solution comprising at least one basal insulin having a pi from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals |
| CN111836616B (en) | 2017-12-07 | 2024-01-16 | 阿道恰公司 | Injectable solution with pH 7 comprising at least one basal insulin with PI between 5.8 and 8.5 and a copolyamino acid with carboxylate charge and hydrophobic group |
| CN112608378B (en) * | 2020-12-09 | 2023-09-08 | 江苏师范大学 | GLP-1/cholecystokinin-1 receptor dual agonist and application thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1202607A (en) | 1968-01-10 | 1970-08-19 | Novo Terapeutisk Labor As | Improvements in or relating to stable glucagon solutions and their preparation |
| US6384016B1 (en) | 1998-03-13 | 2002-05-07 | Novo Nordisk A/S | Stabilized aqueous peptide solutions |
| FR2801226B1 (en) | 1999-11-23 | 2002-01-25 | Flamel Tech Sa | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR VECTORIZATION OF ACTIVE INGREDIENTS AND METHOD OF PREPARATION |
| FR2840614B1 (en) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | POLYAMINOACIDS FUNCTIONALIZED BY ALPHA-TOCOPHEROL AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS |
| FR2860516B1 (en) * | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | TELECHELIC HOMOPOLYAMINOACIDES FUNCTIONALIZED BY HYDROPHOBIC GROUPS AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS |
| WO2009049222A1 (en) * | 2007-10-12 | 2009-04-16 | Curedm, Inc. | Compositions and methods of using the human proislet peptide receptor |
| CA2707861A1 (en) * | 2007-10-30 | 2009-05-07 | Indiana University Research And Technology Corporation | Glucagon antagonists |
| US20110097386A1 (en) | 2009-10-22 | 2011-04-28 | Biodel, Inc. | Stabilized glucagon solutions |
| WO2011138802A1 (en) | 2010-05-07 | 2011-11-10 | Sun Pharma Advanced Research Company Ltd., | Injection solution |
| EP2635296B1 (en) | 2010-11-03 | 2014-12-24 | Arecor Limited | Novel composition comprising glucagon |
| WO2013101749A1 (en) | 2011-12-29 | 2013-07-04 | Latitude Pharmaceuticals, Inc. | Stabilized glucagon nanoemulsions |
| CN113730555A (en) | 2012-01-09 | 2021-12-03 | 阿道恰公司 | Injectable solution of basal insulin and substituted copoly (amino acid) having pH7 and at least PI 5.8 to 8.5 |
| WO2014096440A2 (en) | 2012-12-21 | 2014-06-26 | Novozymes Biopharma Dk A/S | Composition |
| WO2015095389A1 (en) | 2013-12-18 | 2015-06-25 | Aegis Therapeutics, Llc | Compositions for drug administration |
| US9334316B2 (en) | 2014-04-11 | 2016-05-10 | Oregon Health & Science University | Formulations comprising glucagon |
| WO2017211917A1 (en) | 2016-06-07 | 2017-12-14 | Adocia | Compositions in the form of an injectable aqueous solution, comprising human glucagon and a statistical copolyamino acid |
| FR3052071B1 (en) | 2016-06-07 | 2018-09-07 | Adocia | COMPOSITIONS IN THE FORM OF AQUEOUS INJECTABLE SOLUTION COMPRISING GLUCAGON AND A CO-POLYAMINOACID |
-
2018
- 2018-12-07 EP EP18826205.9A patent/EP3720471B1/en active Active
- 2018-12-07 CA CA3084700A patent/CA3084700A1/en active Pending
- 2018-12-07 AU AU2018380993A patent/AU2018380993A1/en active Pending
- 2018-12-07 MA MA051017A patent/MA51017A/en unknown
- 2018-12-07 BR BR112020011484-7A patent/BR112020011484A2/en unknown
- 2018-12-07 CN CN201880088457.9A patent/CN111670042A/en active Pending
- 2018-12-07 SG SG11202005320VA patent/SG11202005320VA/en unknown
- 2018-12-07 JP JP2020530963A patent/JP2021505597A/en active Pending
- 2018-12-07 KR KR1020207019243A patent/KR20200107951A/en unknown
- 2018-12-07 US US16/213,836 patent/US11191812B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020011484A2 (en) | 2020-11-17 |
| EP3720471A1 (en) | 2020-10-14 |
| CN111670042A (en) | 2020-09-15 |
| KR20200107951A (en) | 2020-09-16 |
| JP2021505597A (en) | 2021-02-18 |
| US20190275109A1 (en) | 2019-09-12 |
| MA51017A (en) | 2021-03-17 |
| US11191812B2 (en) | 2021-12-07 |
| CA3084700A1 (en) | 2019-06-13 |
| AU2018380993A1 (en) | 2020-06-11 |
| EP3720471B1 (en) | 2023-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275184A (en) | Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid | |
| IL256085B (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
| IL272141A (en) | Compositions in the form of an injectable aqueous solution comprising at least human insulin a21g and a prandial action glucagon suppressor | |
| HK1223628A1 (en) | The use of novel 7-ketone-6-alkylcholanic acid derivative in preparation of obeticholic acid, and the use thereof in medical field 7--6- | |
| PT3509638T (en) | Cannabidiolic acid esters compositions and uses thereof | |
| ZA202000439B (en) | Liposome compositions comprising weak acid drugs and uses thereof | |
| IL274635A (en) | Stable ascorbic acid compositions and methods of using the same | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| IL275206A (en) | Dried implant composition and injectable aqueous implant formulation | |
| EP3534961A4 (en) | Stable aqueous capsaicin injectable formulations and medical uses thereof | |
| SG11202005320VA (en) | Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid | |
| IL261777A (en) | Palatable compositions including sodium phenylbutyrate and uses thereof | |
| IL275146A (en) | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid | |
| IL253600A0 (en) | Insulin analogues and compositions comprising same | |
| SG11202005319PA (en) | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid | |
| IL241357B (en) | Site 2 insulin analogues and uses thereof | |
| IL290166A (en) | Collagen 7 compositions and use thereof | |
| PL2875832T3 (en) | Implantable paste and its use | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| HK1249894A1 (en) | 10-hydroxy-cis-12-octadecenoic acid alkyl ester and use thereof | |
| IL280389A (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
| IL273967A (en) | Aqueous compositions comprising bilastine and mometasone | |
| GB201511863D0 (en) | Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same | |
| PL3167873T3 (en) | Aqueous solution of condensation products of taurinamide and methylene glycol for use as anti-infective agent in the implantation of devices in cardiac surgery |